Novartis enters AI partnership with Oxford University

21-01-2019

Novartis enters AI partnership with Oxford University

NicoElnino / iStockphoto.com

Novartis and the University of Oxford’s Big Data Institute (BDI) have joined forces to use artificial intelligence (AI) for improving drug development, initially in the areas of multiple sclerosis, dermatology and rheumatology.


Novartis, AI, Oxford University, drug development, partnership, artificial intelligence

LSIPR